PRKDC and neoplasm: Conversely, the enforced expression of MYT1L inhibited cell proliferation and induced a G1 cell cycle arrest (Figure 2E–G), suggesting a tumor suppressor role of MYT1L in DNA-PK-deficient glioblastoma cells, although it suppressed apoptosis (Figure 2H).